Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Somavaratan vs Daily rhGH in Pediatric GHD (VELOCITY)
NCT02339090Phase 3Completed
- Sponsor
- Versartis, Inc.
- Start
- Aug 2015
- Primary completion
- Aug 2017
- Modality
- Fc-Fusion Proteins
01
Overview
A Phase 3 trial of somavaratan in growth hormone deficiency (GHD), sponsored by Versartis, Inc.. Started Aug 2015; status: completed.
02
Drugs
somavaratan
03
Conditions
growth hormone deficiency (GHD)
Beyond the preview
Go deeper on NCT02339090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02339090.